Will Pfizer's Paxlovid Go The Lagevrio Way In India?
Comirnaty – A Lost Opportunity
Executive Summary
While the Medicines Patent Pool has sub-licensed Paxlovid to multiple Indian firms, it isn’t approved in the country yet. It will get there, but molnupiravir’s sales might give an indication of what is in store for Pfizer’s oral antiviral COVID-19 treatment post a lost opportunity with vaccine Comirnaty.